Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)

Future Microbiol. 2020 Sep:15:1287-1305. doi: 10.2217/fmb-2020-0110. Epub 2020 Aug 27.

Abstract

Aim: Despite the similarities in the pathogenesis of the beta coronaviruses, the precise infective mechanisms of SARS-CoV-2 remain unclear. Objective: In this review, we aim to focus on the proposed theories behind the pathogenesis of SARS-CoV-2 and highlight the clinical complications related to COVID-19. Methods: We conducted a literature search in Pubmed, Scopus and Google Scholar for the relevant articles regarding clinical complications and pathogenesis of COVID-19. Results: Related articles were included and discussed. Conclusion: Respiratory system and the lungs are the most commonly involved sites of COVID-19 infection. Cardiovascular, liver, kidneys, gastrointestinal and central nervous systems are involved with different frequencies and degrees of severity.

Keywords: SARS-CoV-2; clinical complications; coronavirus disease 2019; pathogenesis.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Cardiovascular System / pathology
  • Cardiovascular System / virology
  • Central Nervous System / pathology
  • Central Nervous System / virology
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / pathology*
  • Coronavirus Infections / transmission
  • Cytokines / blood
  • Gastrointestinal Tract / pathology
  • Gastrointestinal Tract / virology
  • Humans
  • Kidney / pathology
  • Kidney / virology
  • Liver / pathology
  • Liver / virology
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / transmission
  • Respiratory System / pathology
  • Respiratory System / virology
  • SARS-CoV-2

Substances

  • Cytokines
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2